PUBLISHER: Grand View Research | PRODUCT CODE: 1869674
PUBLISHER: Grand View Research | PRODUCT CODE: 1869674
The global body composition analyzers market size was estimated at USD 714.2 million in 2024 and is projected to reach USD 1,261.6 million by 2033, growing at a CAGR of 6.4% from 2025 to 2033. This growth is driven by rising awareness of obesity and chronic diseases, increasing fitness and wellness trends, and growing adoption of preventive healthcare.
Technological advancements, including portable and user-friendly devices, further fuel demand. In addition, rising investments in sports science, workplace wellness programs, and healthcare infrastructure support market expansion.
The global body composition analyzers industry is experiencing rapid growth, driven by rising obesity rates, increasing metabolic disorders, and heightened consumer health awareness. Obesity is projected to affect 1.13 billion adults by 2030, while in 2024, 506 million people are reported to have metabolic disorders. Traditional metrics like BMI often fail to detect sarcopenic obesity, where high fat and low muscle mass coexist. As a result, clinical guidelines increasingly favor impedance-based body composition analysis, which offers a more precise assessment of fat, muscle, visceral adiposity, and hydration levels. This shift is transforming analyzers from optional tools into essential devices in both preventative and clinical care, making them a core segment of the healthcare diagnostic market.
Healthcare systems and insurers are further fueling market expansion. Payer incentives now reward early risk stratification, as detecting metabolic deterioration early reduces long-term treatment costs. Hospitals and clinics are incorporating body composition analyzers into annual wellness programs, bariatric surgery pathways, and malnutrition screening protocols. For example, the 2025 U.S. Physician Fee Schedule reimburses impedance-based muscle-mass assessments, while European payers increasingly cover sarcopenia diagnostics following the Global Leadership Initiative on Malnutrition. This policy develops lower barriers for small clinics and primary care offices, expanding the market beyond large hospitals. Corporate wellness programs also subsidize onsite scans, further enlarging the reimbursed user base. In Asia Pacific, broader adoption is expected as pilot studies demonstrate reductions in diabetes- and cardiovascular-related expenditures, indicating future regional growth potential.
Government initiatives further bolster the adoption of body composition analyzers. For instance, the All-India Institute of Medical Sciences (AIIMS) in New Delhi procured a body composition analyzer through the Government e-Marketplace (GeM) in early 2024, indicating the government's commitment to integrating advanced diagnostic tools in public healthcare institutions
Consumer-driven demand is equally significant. Awareness of lean mass preservation and healthy aging has risen, with social media highlighting the "skinny-fat" phenomenon. Fitness enthusiasts, athletes, and gym members now prioritize tracking fat percentage, hydration, and visceral fat over simple weight. Retailers report double-digit growth in connected scales, while health apps integrate impedance results with diet and exercise plans. Devices like the Hume Health Body Pod, launched in September 2025, exemplify this trend. Using multi-frequency bioelectrical impedance analysis, the Body Pod provides over 40 health metrics, including body fat, skeletal muscle, total body water, visceral fat index, and basal metabolic rate. Segmental analysis allows users to track specific regions, arms, legs, and trunks, offering actionable insights for training, recovery, and long-term health trends. Its home-based, non-invasive design makes it accessible, bridging the consumer and clinical segments of the market.
Global Body Composition Analyzers Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global body composition analyzers market report based on product, end-use, and region: